EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population



RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population



Plos One 9(10): E110159-E110159



In addition to the clinicopathological parameters, molecular biomarkers are becoming increasingly important in the prognostic evaluation of cancer patients. This study aimed to determine the molecular alterations in the RAS association domain family protein1A gene (RASSF1A) in salivary adenoid cystic carcinoma (ACC) and to evaluate the potential of such alterations as prognostic markers. One hundred and sixty-seven ACC tumor tissues and 50 samples of matched normal salivary gland tissues from the same patients were analyzed for RASSF1A promoter methylation status by bisulfite sequencing PCR (BSP) and/or methylation-specific PCR (MSP). Fifty ACC tumor tissues and matched normal salivary gland tissues were analyzed for loss of heterozygosity (LOH) by examining two microsatellite markers (D3S1478, D3S1621) at 3p21. RASSF1A gene mutations were detected by direct sequencing of all six exons in 50 tumor and normal tissue specimens. Over-all, RASSF1A promoter hypermethylation was detected in 35.3% (59/167) of ACC tissues and was associated with histologically solid tumor pattern (P = 0.002) and advanced TNM stage (P = 0.014). RASSF1A LOH was observed in 18.0% (9/50) of cases, and no somatic mutation of RASSF1A was detected in any cases. RASSF1A promoter methylation was associated with the poor over-all survival (Log-rank test, P <0.001) and disease-free survival (Log-rank test, P <0.001) and identified as an independent predicator of over-all patient survival (P = 0.009) and disease-free survival (P <0.001). It was concluded that RASSF1A methylation is involved in the development, differentiation and progression of ACC and is a strong independent biomarker of poor survival in ACC patients in a Chinese population.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333488

Download citation: RISBibTeXText

PMID: 25302792

DOI: 10.1371/journal.pone.0110159



Related references

High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma. Archives of Pathology & Laboratory Medicine 137(12): 1761-1769, 2014

Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma. Cancer 104(4): 771-776, 2005

Aquaporin-1 promoter hypermethylation is associated with improved prognosis in salivary gland adenoid cystic carcinoma. Otolaryngology--Head and Neck Surgery 150(5): 801-807, 2014

Unfavorable clinical implications for hypermethylation of RUNX3 in patients with salivary gland adenoid cystic carcinoma. Oncology Reports 26(2): 349-357, 2011

High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma. Journal of Clinical Pathology 61(6): 744-749, 2008

Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma. Pediatric Blood & Cancer 49(3): 240-249, 2006

Primary adenoid cystic carcinoma of the skin. A clinical, histological, and immunocytochemical comparison with adenoid cystic carcinoma of salivary glands and adenoid basal cell carcinoma. American Journal of Dermatopathology 8(1): 2-13, 1986

High expression of SOX2 is associated with poor prognosis in patients with salivary gland adenoid cystic carcinoma. International Journal of Molecular Sciences 15(5): 8393-8406, 2015

Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population. Journal of International Medical Research 37(6): 1882-1889, 2010

Factors influencing survival of patients with adenoid cystic carcinoma of the salivary glands. Journal of Oral and Maxillofacial Surgery 45(12): 1005-1010, 1987

Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients. Cancer Science 95(9): 736-740, 2004

Development of a predicting model of survival rates for patients with salivary adenoid cystic carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi 41(6): 350-353, 2006

Expression of p16 protein and hypermethylation status of its promoter gene in adenoid cystic carcinoma of the head and neck. Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties 65(1): 26-32, 2003

Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. International Journal of Oncology 28(3): 767-773, 2006